Home›Stock Screener›Tyche Industries

Tyche Industries Share Price Today | Stock Price & Tyche Industries Share Screener

TYCHE Pharmaceuticals
Live Share Price BSE
₹103.50
▼ -1.45 (-1.38%)
2026-10-05 00:00:00

As of October 5, 2026, the live Tyche Industries share price (BSE: TYCHE) is ₹103.50, down 1.38% from the previous close, with shares trading between ₹103.00 and ₹108.85 in today's trading session, and a 52-week range of ₹99.80–₹144.35. Check Tyche Industries 52-week for the annual price range and momentum. Use the Tyche Industries stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Tyche Industries opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹60 and net income of ₹4, with EBITDA of ₹8, an operating margin of -3.0% and a profit margin of 6.7%.

Tyche Industries Market Cap ₹106.11 Cr.
TYCHE P/E Ratio (TTM) 24.13
Tyche Industries P/B Ratio 0.77
EPS (TTM) ₹6.70
Dividend Yield 3.33%
Debt to Equity -
TYCHE 52 Week High ₹144.35
Tyche Industries 52 Week Low ₹99.80
Operating Margin -3.00%
Profit Margin 6.67%
TYCHE Revenue (TTM) ₹60.00
EBITDA ₹8.00
Net Income ₹4.00
Total Assets ₹148.00
Total Equity ₹141.00

Tyche Industries Share Price Chart

Track the current stock price of Tyche Industries with an interactive chart. Analyse TYCHE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Tyche Industries stock quote in one place.

The quote of ₹103.50 sits between the 52-week low of ₹99.80 and the 52-week high of ₹144.35, and the latest session moved -1.38% from the previous close.

Tyche Industries Company Profile - Fundamental Screener

Screen Tyche Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TYCHE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE443B01012.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE443B01012

Tyche Industries Balance Sheet Screener

Screen TYCHE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹148, up from ₹147 in 2025.

Latest statistics put total assets at ₹148 and shareholder funds at ₹141.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 148 147 135 137 120 117 95 74 67 61
Current Assets 108 121 113 112 101 96 75 53 45 32
Fixed Assets 19 17 18 17 17 18 18 19 20 27

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 1 1 1 3 3 3 3 3 3 3
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 141 137 127 117 104 96 77 60 53 48
Share Capital 10 10 10 10 10 10 10 10 10 10
Reserves & Surplus 130 127 117 107 94 86 67 50 43 38

Tyche Industries Income Statement Screener - Profit & Revenue Analysis

Screen Tyche Industries income statement and profit fundamentals. Analyze TYCHE quarterly results. Tyche Industries reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹60 and net profit was ₹4, equal to earnings per unit of ₹4.30, at an operating margin of -3%.

In that period expenses were ₹52, interest cost ₹0 and tax ₹2. The next period listed, 2026-March, shows revenue of ₹63 and net profit of ₹7.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 60 63 73 75 80 66 83 77 57 53 45 56 64
Expenses 52 51 54 57 59 51 54 52 45 43 37 51 57

Operating Costs and Margins

EBITDA 8 12 19 19 21 15 30 25 12 11 8 5 7
Operating Profit % -3.00% 4.00% 17.00% 18.00% 21.00% 18.00% 32.00% 29.00% 17.00% 18.00% 14.00% 5.00% 11.00%
Depreciation 2 2 2 2 2 2 2 2 2 2 2 2 3
Interest 0 0 0 0 0 0 0 0 0 0 0 0 1

Profit and Earnings

Profit Before Tax 6 10 17 17 19 13 27 23 10 9 6 3 3
Tax 2 3 4 4 5 3 7 6 3 3 3 0 1
Net Profit 4 7 12 12 14 9 20 18 7 6 3 3 2
EPS 4.30 6.70 12.19 11.78 13.74 9.18 19.35 17.14 6.97 5.72 3.02 2.42 1.89

Tyche Industries Cash Flow Screener - Liquidity Fundamentals

Screen TYCHE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹3, and net cash flow was an outflow of ₹9.

Over the same period, investing activities used ₹9 and financing activities used ₹3.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 3 9 8 6 5 15 15 4 5 11
Investing Activities -9 0 4 -3 3 0 2 1 6 1

Financing and Net Cash

Financing Activities -3 -3 -2 -2 -1 -1 -1 0 -1 -11
Net Cash Flow -9 6 10 2 7 15 17 4 11 1

Tyche Industries Shareholding Pattern Screener

See Tyche Industries shareholding pattern with promoter, FII, and DII holdings. Check Tyche Industries promoter holding and ownership changes for TYCHE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 61.97%, foreign institutions 0.00%, domestic institutions 0.00% and the public 26.55%, spread across 6,952 shareholders.

The shareholder count was 6,952 in 2026-Mar, compared with 6,786 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 61.97% 61.97% 61.97% 61.97% 62.05% 61.97% 61.97% 61.97%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 26.55% 26.57% 26.91% 26.76% 26.57% 26.51% 27.80% 27.58%
Other Holding 11.48% 11.47% 11.13% 11.27% 11.38% 11.52% 10.23% 10.45%
Shareholder Count 6,952 6,786 7,425 7,376 7,257 7,152 7,867 7,477

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Tyche Industries. Tyche Industries dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹3.50 per unit for 2026-March, a yield of 3.33%, compared with ₹3.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹3.50, ₹3.00 and ₹2.50 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹3.50 3.33%
2025-March ₹3.00 3.01%
2024-March ₹2.50 1.88%
2023-March ₹0.00 0.00%
2022-March ₹1.50 1.09%
2021-March ₹1.00 0.72%
2020-March ₹1.00 0.59%
2019-March ₹0.50 0.67%
2018-March ₹0.50 0.72%
2017-March ₹0.50 0.47%

Tyche Industries Stock Index Membership - Nifty & Sensex

See which indices include Tyche Industries stock. Check TYCHE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Tyche Industries is not part of any tracked indices.
Only major market indices are tracked in our system.

Tyche Industries Market Events Screener - Corporate Actions

Get Tyche Industries corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Tyche Industries stock events that may affect TYCHE share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Dividend dated September 23, 2026, with a record date of September 23, 2026.

It is followed by Quarterly Result Announcement dated August 11, 2026 and Quarterly Result Announcement dated May 28, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-23 2026-09-23 Dividend ₹ 3.50 /share -13.30%
2026-08-11 2026-08-11 Quarterly Result Announcement NA 0.73%
2026-05-28 2026-05-28 Quarterly Result Announcement NA -1.98%
2026-02-12 2026-02-12 Quarterly Result Announcement NA 12.30%
2025-11-13 2025-11-13 Quarterly Result Announcement NA -1.27%
2025-09-30 2025-09-30 Annual General Meeting NA 0.66%
2025-09-19 2025-09-19 Dividend ₹ 3.00 /share -3.79%
2025-08-12 2025-08-12 Quarterly Result Announcement NA -0.15%
2025-05-28 2025-05-28 Quarterly Result Announcement NA 0.44%
2025-02-13 2025-02-13 Quarterly Result Announcement NA -9.34%
2024-11-13 2024-11-13 Quarterly Result Announcement NA 13.99%
2024-09-30 2024-09-30 Annual General Meeting NA 2.68%
2024-09-20 2024-09-20 Dividend ₹ 2.50 /share -6.58%
2023-08-22 2023-08-22 Dividend ₹ 2.00 /share -4.90%
2022-09-22 2022-09-24 Dividend ₹ 1.50 /share 18.06%

Tyche Industries Competitors Screener - Peer Stocks Comparison

Screen TYCHE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 427,010 35.84 61,674 12.69% 11,565 33.78
Divis Laboratories 244,125 84.36 11,067 13.95% 2,568 49.73
Torrent Pharmaceuticals 181,512 84.01 13,886 20.34% 2,138 41.48
Zydus Life Science 113,616 24.88 27,658 17.64% 5,026 46.18
Cipla 107,890 32.42 29,045 2.24% 3,870 32.87
Laurus Labs 106,517 98.56 6,868 22.01% 890 56.11
Mankind Pharma 102,394 50.48 14,636 14.85% 1,938 55.53
Dr Reddys Laboratories 100,412 31.47 35,059 3.90% 4,158 52.91
Aurobindo Pharma 96,370 25.97 34,145 5.56% 3,503 49.89
Lupin 91,961 16.71 29,039 26.75% 5,356 29.12

Tyche Industries Company Announcements - News & Reports Screener

Screen TYCHE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 2, 2026.

The next most recent announcements are dated October 1, 2026 and September 27, 2026.

Date Update Actions
2026-10-02 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-10-01 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-27 Closure of Trading Window -
2026-09-05 Corrigendum To The Annual Report For The Financial Year 2025-26 -
2026-09-03 Intimation Under Regulations 30 And 36(1)(B) Of The SEBI Listing Regulations. -
2026-09-03 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-03 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-02 Reg. 34 (1) Annual Report. -
2026-09-02 Intimation Of Record Date For The Purpose Of Payment Of Final Dividend For The F.Y. 2025-26. -
2026-09-02 Intimation Of Book Closure For 28Th Annual General Meeting -
2026-09-02 Notice Of 28Th Annual General Meeting -
2026-09-02 Board Meeting Outcome for Outcome Of Board Meeting For (I)Approval Of 28Th AGM Annual Report (Ii)Notice Of 28Th AGM -
2026-08-13 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-11 Unaudited Financial Results For The Quarter Ended June 30 2026 -
2026-08-11 Board Meeting Outcome for Outcome Of Board Meeting Held On 11Th August 2026 -
2026-08-04 Board Meeting Intimation for Approval Of Un-Audited Financial Results For The 1St Quarter Ended 30Th June 2026. -
2026-07-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-07 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-24 Closure of Trading Window -
2026-05-31 Announcement under Regulation 30 (LODR)-Newspaper Publication -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹103.50, within a 52-week range of ₹99.80 to ₹144.35. The P/E ratio is 24.13 and the P/B ratio is 0.77, with earnings per unit of ₹6.70. Market capitalisation stands at ₹106.11 Cr and the dividend yield is 3.33%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.